abstract |
The present invention provides compounds of formula I and tautomers, enantiomers, or pharmaceutically acceptable salts, crystal forms, hydrates or solvates thereof. The experimental results show that the compounds of the present invention can effectively combine with STING, and as STING agonists, the compounds of the present invention can be used to treat various diseases, especially leukemia. |